S-1 EX-FILING FEES 0001677077 N/A N/A 0001677077 1 2026-08-21 2026-08-21 0001677077 2026-08-21 2026-08-21 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

Alzamend Neuro, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common stock, par value $0.0001 per share   (1)   Other   98,388,305   $ 1.4975   $ 147,336,486.74   0.0001381   $ 20,347.17
                                           
Total Offering Amounts:   $ 147,336,486.74         20,347.17
Total Fees Previously Paid:                
Total Fee Offsets:               0.00
Net Fee Due:             $ 20,347.17

__________________________________________
Offering Note(s)

(1) (a) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock that become issuable upon conversion of the shares of Series D convertible preferred stock (the “Series D Preferred Shares”) issued or issuable by Alzamend Neuro, Inc. (the “Company”) to Ault Lending, LLC (the “Selling Stockholder”) pursuant to that certain securities purchase agreement by and between the Company and the Selling Stockholder dated as of July 31, 2026 (the “Purchase Agreement”), as amended by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of the Company’s common stock (“Common Stock”), as applicable.

(b) Represents shares of Common Stock issuable upon conversion of the Series D Preferred Shares to be sold by the Company to the Selling Stockholder pursuant to the Purchase Agreement.

(c) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the Common Stock, as reported on The Nasdaq Capital Market on August 14, 2026, which date is within five business days prior to the filing of this registration statement.